Pulmokine
About:
Pulmokine is a privately held biopharmaceutical company
Website: http://pulmokine.net
Top Investors: Broadview Ventures
Description:
Pulmokine is a privately held biopharmaceutical company. Our focus is on pulmonary disease and kinase inhibitor technology, hence our name Pulmokine. The mission of Pulmokine is to develop new therapies for hard-to-treat lung conditions like pulmonary arterial hypertension (PAH) and related disorders. These include pulmonary arterial fibrosis/interstitial lung disease, sarcoidosis and lung cancer.
Total Funding Amount:
$1M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Rensselaer, New York, United States
Founded Date:
2007-01-01
Contact Email:
info(AT)pulmokine.net
Founders:
Larry Zisman
Number of Employees:
11-50
Last Funding Date:
2015-03-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai